BECN1 and serum lipopolysaccharide activity: Our evaluation of TB-peptide previously in the endotoxemia model (Sun et al., 2018) and currently in the pneumonia-induced sepsis model have provided novel evidence supporting the notion that pharmacological approaches targeting Beclin-1 signaling possess important therapeutic values for sepsis.